[Activation of ifosfamide in man and animal].
D000284:Administration, Oral; D000477:Alkylating Agents / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D000704:Analysis of Variance; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003520:Cyclophosphamide / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005021:Ethylamines / Q000097:blood / Q000378:metabolism / Q000652:urine; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008297:Male; D008954:Models, Biological; D009369:Neoplasms / Q000378:metabolism; D010078:Oxazines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D017976:Phosphorus Acids / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011725:Pyridines; D051381:Rats; D012737:Sex Factors; D013997:Time Factors
D000477:Alkylating Agents; D005021:Ethylamines; D010078:Oxazines; D017976:Phosphorus Acids; D011725:Pyridines; D003520:Cyclophosphamide
Die Aktivierung von Ifosfamid an Mensch und Tier.